{"id":"NCT00818883","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension","officialTitle":"A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study of the TAK 491 Plus Chlorthalidone Fixed-Dose Combination Compared With TAK-491 and Hydrochlorothiazide Coadministration Therapy in Subjects With Moderate to Severe Essential Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02","primaryCompletion":"2009-11","completion":"2009-11","firstPosted":"2009-01-08","resultsPosted":"2012-02-07","lastUpdate":"2012-02-07"},"enrollment":609,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"Azilsartan medoxomil and chlorthalidone","otherNames":["TAK-491","TAK-491CLD"]},{"type":"DRUG","name":"Azilsartan medoxomil and hydrochlorothiazide","otherNames":["TAK-491","TAK-491CLD"]}],"arms":[{"label":"Azilsartan Medoxomil 40 mg/Chlorthalidone 12.5 mg QD","type":"EXPERIMENTAL"},{"label":"Azilsartan Medoxomil 40 mg + Hydrochlorothiazide 12.5 mg QD","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare the antihypertensive effect of chlorthalidone vs hydrochlorothiazide when each is used with azilsartan medoxomil, once daily (QD), in participants with moderate to severe essential hypertension.","primaryOutcome":{"measure":"Change From Baseline in Trough, Sitting, Clinic Systolic Blood Pressure","timeFrame":"Baseline, Week 6 and Week 10.","effectByArm":[{"arm":"Azilsartan Medoxomil 40 mg/Chlorthalidone 12.5 mg QD","deltaMin":-35.1,"sd":0.97},{"arm":"Azilsartan Medoxomil 40 mg + Hydrochlorothiazide 12.5 mg QD","deltaMin":-29.5,"sd":0.98}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":53,"countries":["United States","Russia"]},"refs":{"pmids":["22939358"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":302},"commonTop":["Dizziness","Blood creatinine increased","Headache"]}}